Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite ...

Among others, following stocks were impacted: Healthcare Technology for Providers company Omnicell (NASDAQ:OMCL) fell 5.4%. Is now the time to buy Omnicell? Access our full analysis report here ...

For anyone who wants to understand Omnicell's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$5.2m due to unusual ...

Omnicell OMCL underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light ...